Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Microbot Medical Inc
(NQ:
MBOT
)
0.9440
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Microbot Medical Inc
< Previous
1
2
3
4
5
6
Next >
Looking Into Microbot Medical's Recent Short Interest
February 02, 2024
Via
Benzinga
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
January 30, 2024
All of the cash payable to the plaintiffs in the settlement will be covered by Microbot’s insurance carrier and will not impact company's cash position
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
January 18, 2024
Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical study
From
Microbot Medical Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 01, 2024
Via
Benzinga
Gold Moves Lower; Microbot Medical Shares Slide
December 29, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 29, 2023
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 29, 2023
Via
Benzinga
Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet
December 29, 2023
U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Friday. The Dow traded down 0.34% to 37,583.72 while the NASDAQ fell 0.73% to 14,984.98. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 29, 2023
Via
Benzinga
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
December 29, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
December 28, 2023
Via
Benzinga
Gold Moves Lower; US Crude Stocks Decline Last Week
December 28, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 28, 2023
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 28, 2023
Via
Benzinga
Crude Oil Down 1%; US Wholesale Inventories Fall In November
December 28, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up 0.14% to 37,708.15 while the NASDAQ rose 0.19% to 15,127.17. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Microbot Medical Stock Is Moving Higher: What's Going On?
December 28, 2023
Microbot Medical Inc (NASDAQ: MBOT) shares are trading higher Thursday after the company announced the completion of its GLP pivotal pre-cl
Via
Benzinga
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
December 28, 2023
The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
December 14, 2023
The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular treatments
From
Microbot Medical Inc.
Via
GlobeNewswire
3 Stocks at the Forefront of Medical Robotics
December 10, 2023
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid.
Via
InvestorPlace
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study
December 07, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
November 21, 2023
The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase.
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
November 13, 2023
The V&V process is an additional key milestone toward regulatory submission and is required to continue the regulatory process with the FDA
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
November 08, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study
October 31, 2023
Follow up visual examination three days after the procedures using the LIBERTY Robotic Surgical System, confirms 100% success rate in reaching the targets with no adverse events
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024
October 24, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company
October 19, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System
October 17, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial
September 27, 2023
The engagement is an additional step in the Company's path towards marketing clearance with the FDA
From
Microbot Medical Inc.
Via
GlobeNewswire
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
September 20, 2023
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.
Via
Benzinga
Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023
September 08, 2023
The presentation follows successful extensive uses of the Company’s endovascular robotic system in pre-clinical studies
From
Microbot Medical Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.